eli lilly ceo ricks on sales forecast, alzheimer's drug
Published 3 years ago • 1.5K plays • Length 6:07Download video MP4
Download video MP3
Similar videos
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
3:48
investors should trim into the riskiest parts of the market, says john hancock's emily roland
-
17:28
is eli lilly (lly) stock finally an undervalued buy after 20% drop? | lly stock analysis |
-
3:08
why elon musk's mother is popular in china
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
4:03
eli lilly ceo: alzheimer's drug trial shows slowed disease progression by 40-60% in early patients
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
1:54
lilly's alzheimer's gamble aims to fill $10 billion gap: video
-
10:14
eli lilly ceo on drug pricing and diabetes treatment
-
34:07
eli lilly ceo discusses covid-19 treatments, and biogen's fda approval of new alzheimer's drug
-
4:12
eli lilly ceo david ricks explains q1 earnings miss, lowered forecast
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
4:14
eli lilly ceo david ricks on glp-1 and obesity drugs
-
5:56
eli lilly ceo says science will win in covid fight
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
5:54
eli lilly ceo on 3q results, drug-pricing reforms
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline
-
23:50
eli lilly ceo says virus will be 'endemic'